• Contents
• Letter of transmittal
• User guide
• part 1: overview of the nba and the blood sector
• part 2: highlights of 2011–12
• NBA's Performance
  (PARTS 3,4, AND 5)
• part 3: performance: securing the supply of blood and blood products
• part 4: performance: improving the sector and its management of risk
• part 5: performance: supporting appropriate and safe use of blood and blood products
  • Introduction
  • National Guidelines and Criteria for Use
  • Standards, Accreditation and Stewardship
  • Education
  • Clinical Governance and Data Systems
  • Networks and Communications
  • Quality Improvement Initiatives
• part 6: Corporate management
• part 7: financial management and accountability
• part 8: appendices

Part 5: Performance: Supporting Appropriate and Safe Use of Bloof and Blood Products

NETWORKS AND COMMUNICATION

Since commencing a guidelines and clinical development program in 2006, the NBA has established a wide network of clinicians who provide expert advice to guide NBA initiatives.

These key advisors often represented colleges and societies and act as champions to communicate evidence-based recommendations arising from the guideline development process. These key experts have provided numerous presentations to clinical audiences in both Australia and overseas.

However, the NBA recognises the need to further develop and support clinical practice networks to enhance the effectiveness of initiatives to translate evidence into practice in the clinical setting. This is a key area for development into the future.

With the appointment of a new General Manager, greater emphasis is being placed on the NBA's communications function to support the implementation of clinical and other quality improvement initiatives.